Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Allergy to insect stings: a review.

Literature DB >> 3973889

Allergy to insect stings: a review.

P W Ewan.

Abstract

Entities: Disease

Mesh：

Substances：
Bee Venoms
Wasp Venoms

Year: 1985 PMID： 3973889 PMCID： PMC1289640 DOI： 10.1177/014107688507800312

Source DB: PubMed Journal: J R Soc Med ISSN： 0141-0768 Impact factor: 5.344

× No keyword cloud information.

15 in total

1. Insect allergy: the state of the art.

Authors: L M Lichtenstein; M D Valentine; A K Sobotka
Journal: J Allergy Clin Immunol Date: 1979-07 Impact factor: 10.793

2. Studies of 400 Hymenoptera sting deaths in the United States.

Authors: J H Barnard
Journal: J Allergy Clin Immunol Date: 1973-11 Impact factor: 10.793

3. Role of cell-mediated immunity in Hymenoptera allergy.

Authors: R L Case; L C Altman; P P VanArsdel
Journal: J Allergy Clin Immunol Date: 1981-11 Impact factor: 10.793

4. A controlled trial of immunotherapy in insect hypersensitivity.

Authors: K J Hunt; M D Valentine; A K Sobotka; A W Benton; F J Amodio; L M Lichtenstein
Journal: N Engl J Med Date: 1978-07-27 Impact factor: 91.245

5. Dose dependence of Hymenoptera venom immunotherapy.

Authors: D B Golden; A Kagey-Sobotka; M D Valentine; L M Lichtenstein
Journal: J Allergy Clin Immunol Date: 1981-05 Impact factor: 10.793

6. Regimens of Hymenoptera venom immunotherapy.

Authors: D B Golden; M D Valentine; A Kagey-Sobotka; L M Lichtenstein
Journal: Ann Intern Med Date: 1980-05 Impact factor: 25.391

7. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.

Authors: D M Kemeny; M MacKenzie-Mills; M G Harries; L J Youlten; M H Lessof
Journal: J Allergy Clin Immunol Date: 1983-10 Impact factor: 10.793

8. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy.

Authors: D B Golden; D A Meyers; A Kagey-Sobotka; M D Valentine; L M Lichtenstein
Journal: J Allergy Clin Immunol Date: 1982-06 Impact factor: 10.793

9. Effects of passive antibody in bee venom anaphylaxis.

Authors: M H Lessof; A K Sobotka; L M Lichtenstein
Journal: Johns Hopkins Med J Date: 1978-01

Review 10. Allergy to bee stings: a review.

Authors: A W Frankland; M H Lessof
Journal: J R Soc Med Date: 1980-11 Impact factor: 18.000

6 in total

Allergy to insect stings: a review.

1. Insect allergy: the state of the art.

2. Studies of 400 Hymenoptera sting deaths in the United States.

3. Role of cell-mediated immunity in Hymenoptera allergy.

4. A controlled trial of immunotherapy in insect hypersensitivity.

5. Dose dependence of Hymenoptera venom immunotherapy.

6. Regimens of Hymenoptera venom immunotherapy.

7. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.

8. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy.

9. Effects of passive antibody in bee venom anaphylaxis.

Review 10. Allergy to bee stings: a review.

1. Sensitivity to insect stings in patients taking anti-inflammatory drugs.

2. Hyposensitisation.

3. Desensitising vaccines: an allergist's view.

4. Deaths from bee stings: a report of three cases from Pretoria, South Africa.

5. Hymenoptera stings and serum venom-specific IgE in Japanese Pest-control operators.

Review 6. Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party.